Position in QURE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,691,341
+$10,595 QoQ
Shares Held
103,446
+47.3% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. QURE ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in QURE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,691,341 | 103,446 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,680,746 | 70,236 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $632,905 | 10,843 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $152,531 | 10,942 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $130,698 | 12,330 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $217,112 | 12,294 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $53,199 | 10,791 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $48,634 | 10,856 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $58,276 | 11,207 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $61,450 | 9,077 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $613,146 | 91,378 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $587,462 | 51,262 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,021,399 | 50,715 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $287,295 | 12,673 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $305,317 | 16,275 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $403,945 | 21,671 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $363,097 | 20,094 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $313,525 | 15,117 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,113,364 | 190,983 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $569,183 | 18,480 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $623,465 | 18,506 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,453,833 | 40,239 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,165,926 | 31,657 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,327,105 | 29,452 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,584,353 | 33,390 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||